C. Pomel

发表

Prospective study of the impact of using the 21-gene recurrence score assay on clinical decision making in women with estrogen receptor-positive, HER2-negative, early-stage breast cancer in France.

A. Roquancourt, R. Rouzier, F. Penault-Llorca, 2012 .

Results of conservative management of epithelial malignant and borderline ovarian tumours.

R. Rouzier, D. Atallah, P. Morice, 2003, Human reproduction update.

Endoscopic muscular latissimus dorsi flap harvesting for immediate breast reconstruction after skin sparing mastectomy.

P. Lasser, D. Atallah, C. Pomel, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer.

C. Pomel, S. Gouy, G. Ferron, 2016, Gynecologic oncology.

Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 cases.

R. Rouzier, P. Morice, C. Pomel, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study

R. Rouzier, F. Guyon, P. Colombo, 2021, Cancers.

Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy: A Non-randomized Study

D. Provencher, J. Brunet, C. Pomel, 1999 .

INTERVAL DEBULKING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN ADVANCED OVARIAN CANCER - RETROSPECTIVE STUDY COMPARING SURGERY AFTER 3 CYCLES OR MORE OF CHEMOTHERAPY.

C. Pomel, J. Faucheron, D. Riethmuller, 2022, Journal of gynecology obstetrics and human reproduction.

Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.

C. Genestie, R. Rouzier, F. Guyon, 2019, European journal of cancer.

How should we stage and tailor treatment strategy in locally advanced cervical cancer? Imaging versus para-aortic surgical staging

C. Pomel, D. Querleu, G. Ferron, 2020, International Journal of Gynecological Cancer.

Exclusive radiotherapy for primary squamous cell carcinoma of the vagina.

C. Haie-meder, N. Sanfilippo, A. Gerbaulet, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Survival in cervix cancer patients treated with radiotherapy followed by radical surgery.

C. Haie-meder, R. Rouzier, R. de Crevoisier, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study.

D. Elias, P. Morice, C. Pomel, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Exenterative surgery for recurrent gynaecological malignancies.

A. Bryant, C. Pomel, D. Barton, 2014, The Cochrane database of systematic reviews.

The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.

D. Berton, F. Guyon, N. Radosevic-Robin, 2020, Gynecologic oncology.

Cytoreductive surgery in ovarian cancer

K. Reynolds, J. Shepherd, C. Pomel, 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.

Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network

D. Berton, P. Colombo, I. Treilleux, 2022, Cancers.

Prognostic Value of Initial Tumor Parameters After Metastatic Relapse

M. Mouret-Reynier, C. Abrial, F. Kwiatkowski, 2011, Cancer investigation.

Surgical Complexity Impact on Survival After Complete Cytoreductive Surgery for Advanced Ovarian Cancer

E. Darai, F. Guyon, C. Ngô, 2016, Annals of Surgical Oncology.

Maximal Cytoreduction in Patients With FIGO Stage IIIC to Stage IV Ovarian, Fallopian, and Peritoneal Cancer in Day-to-Day Practice: A Retrospective French Multicentric Study

E. Darai, P. Morice, C. Pomel, 2012, International Journal of Gynecologic Cancer.

Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.

C. Pomel, D. Querleu, G. Ferron, 2011, Gynecologic oncology.

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

M. Mouret-Reynier, C. Abrial, F. Kwiatkowski, 2011, Breast.

Cytoreductive surgery for advanced stages of ovarian cancer.

C. Pomel, J. Dauplat, G. le Bouëdec, 2000, Seminars in surgical oncology.

Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.

C. Pomel, S. Gouy, O. Glehen, 2014, Journal of visceral surgery.

Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.

S. Msika, F. Guyon, E. Decullier, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.

R. Rouzier, D. Atallah, P. Morice, 2003, Journal of the American College of Surgeons.

Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2).

F. Guyon, G. Mage, A. Bats, 2021, European journal of cancer.

[Retroperitoneal lymphadenectomy and survival of patients treated for an advanced ovarian cancer: the CARACO trial].

C. Pomel, J. Rodier, P. Mathevet, 2011, Journal de gynecologie, obstetrique et biologie de la reproduction.

The “Definitive” Trial of Surgical Cytoreduction in Advanced-Stage Ovarian Cancer

J. Donovan, D. Chi, I. Vergote, 2013, International Journal of Gynecologic Cancer.

Comment on “Primary Chemotherapy for Inoperable Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without Delayed Debulking Surgery”

C. Pomel, D. Barton, R. Naik, 2012, International Journal of Gynecologic Cancer.

A statement for extensive primary cytoreductive surgery in advanced ovarian cancer

C. Pomel, D. Barton, 2009 .

A statement for extensive primary cytoreductive surgery in advanced ovarian cancer

I. McNeish, C. Pomel, D. Barton, 2008, BJOG : an international journal of obstetrics and gynaecology.

Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.

P. Morice, C. Pomel, P. Duvillard, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage?

C. Pomel, D. Querleu, T. Filleron, 2011, Gynecologic oncology.

Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer

E. Darai, R. Rouzier, C. Pomel, 2009, BJOG : an international journal of obstetrics and gynaecology.

Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: results of a multivariate analysis.

C. Haie-meder, D. Atallah, P. Morice, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant therapy in patients with FIGO stage IIIc/IV ovarian, tubal, or peritoneal adenocarcinoma, initially unresectable.

R. Rouzier, F. Guyon, P. Colombo, 2014 .

Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer

D. Blaise, X. Durando, C. Pomel, 2000, Bone Marrow Transplantation.

Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients.

C. Haie-meder, C. Genestie, D. Atallah, 2003, European journal of gynaecological oncology.

Malignant effusions and immunogenic tumour-derived exosomes

L. Zitvogel, F. André, G. Raposo, 2002, The Lancet.

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.

M. Mouret-Reynier, P. Gimbergues, C. Pomel, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Risk Factors Associated With Complications After Unilateral Immediate Breast Reconstruction: A French Prospective Multicenter Study

P. Rouanet, C. Pomel, K. Clough, 2021, In Vivo.

[Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme].

F. Penault-Llorca, Y. Bignon, C. Pomel, 2011, Annales de pathologie.

Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer.

F. Penault-Llorca, Y. Bignon, F. Mishellany, 2009, European journal of cancer.

Systematic (complete) para‐aortic lymphadenectomy: description of a novel surgical classification with technical and anatomical considerations

C. Pomel, A. Jeyarajah, G. Ferron, 2012, BJOG : an international journal of obstetrics and gynaecology.

Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort.

R. Rouzier, P. Colombo, I. Ray-Coquard, 2022, Gynecologic oncology.

Laparoscopic prophylactic surgery for HNPCC gene mutation carrier: has the time come?

M. Pocard, P. Lasser, C. Pomel, 2003, The Lancet. Oncology.

Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study)

R. Rouzier, M. Canis, C. Pomel, 2021, International Journal of Gynecological Cancer.

Real-World Data on Newly Diagnosed BRCA-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database

R. Rouzier, I. Ray-Coquard, A. Floquet, 2022, Cancers.

Prognostic factors for patients with advanced stage serous borderline tumours of the ovary.

C. Haie-meder, D. Atallah, P. Morice, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey.

S. Msika, F. Guyon, M. Pocard, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy.

R. Rouzier, D. Elias, C. Pomel, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Should We Abandon Systematic Pelvic and Paraaortic Lymphadenectomy in Low-Grade Serous Ovarian Cancer?

C. Ngô, C. Pomel, G. Ferron, 2020, Annals of Surgical Oncology.

Creation of the Miami Pouch During Laparoscopic-Assisted Pelvic Exenteration: The Initial Experience

C. Pomel, D. Querleu, G. Ferron, 2008, International Journal of Gynecologic Cancer.

Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study

I. Fournier, F. Guyon, C. Pomel, 2023, Cancers.

Laparoscopic total pelvic exenteration for cervical cancer relapse.

J. Bourgain, R. Rouzier, M. Pocard, 2003, Gynecologic oncology.

Networking for ovarian rare tumors: a significant breakthrough improving disease management

N. Chiannilkulchai, C. Genestie, F. Penault-Llorca, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study.

D. Atallah, P. Morice, C. Pomel, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.

A. Reuss, P. Hillemanns, F. Guyon, 2021, The New England journal of medicine.

Long-term follow-up after laparoscopic management of endometrial cancer: a 15-year cohort study

K. Jardon, F. Kwiatkowski, M. Canis, 2011, Gynecological Surgery.

Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study.

R. Rouzier, D. Atallah, P. Morice, 2003, Gynecologic oncology.

Laparoscopic radical hysterectomy for cervical cancer

M. Canis, G. Mage, C. Pomel, 1998 .

Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials

F. Penault-Llorca, M. Mouret-Reynier, C. Abrial, 2009, International journal of general medicine.

Laparoscopic hysterectomy.

M. Canis, G. Mage, C. Pomel, 1995, Current opinion in obstetrics & gynecology.

Long-term follow-up after laparoscopic management of endometrial cancer in the obese: a fifteen-year cohort study.

K. Jardon, F. Kwiatkowski, M. Canis, 2011, Journal of minimally invasive gynecology.

The role of lymph node resection in ovarian cancer: analysis of the surveillance, epidemiology, and end results (SEER) database

R. Rouzier, C. Pomel, E. Daraï, 2010, BJOG : an international journal of obstetrics and gynaecology.

[Morbidity of pelvic lymphadenectomy and para-aortic lymphadenectomy in endometrial cancer].

M. Canis, C. Pomel, N. Bourdel, 2015, Bulletin du cancer.

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

F. Penault-Llorca, N. Radosevic-Robin, F. Kwiatkowski, 2018, BMC Cancer.

Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.

R. Rouzier, F. Penault-Llorca, A. de Roquancourt, 2015, The oncologist.

Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.

R. Rouzier, P. Colombo, I. Ray-Coquard, 2021, Gynecologic oncology.

[Gynecological cancers and pregnancy: the point of view of the oncology gynecologist].

C. Haie-meder, P. Morice, C. Pomel, 2002, Bulletin du cancer.

Laparoscopic hand-assisted Miami Pouch following laparoscopic anterior pelvic exenteration.

C. Pomel, D. Castaigne, 2004, Gynecologic oncology.

Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.

K. Reynolds, A. Bryant, C. Pomel, 2013, The Cochrane database of systematic reviews.

LRH with Anterior and Posterior Exenteration: Surgical Perspectives

C. Pomel, D. Querleu, B. Malavaud, 2018 .

Analysis of a Continuous Series of 34 Young Patients With Early-Stage Cervical Cancer Selected for a Vaginal Radical Trachelectomy: Should “Staging” Conization Be Systematically Performed Before This Procedure?

C. Haie-meder, P. Morice, C. Uzan, 2012, International Journal of Gynecologic Cancer.

[Bowel endometriosis. Eight cases of colorectal resection].

K. Slim, M. Canis, G. Mage, 1996, Journal de gynecologie, obstetrique et biologie de la reproduction.

Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer – final analysis of AGO DESKTOP III/ENGOT- ov20

A. Reuss, F. Guyon, I. Vergote, 2020, Geburtshilfe und Frauenheilkunde.

Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer.

D. Atallah, P. Morice, C. Pomel, 2003, Journal of the American College of Surgeons.

Quality of life after mastectomy with or without immediate breast reconstruction

C. Abrial, X. Durando, C. Pomel, 2017, The British journal of surgery.

[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].

C. Genestie, R. Rouzier, F. Guyon, 2018, Bulletin du cancer.

[Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure].

C. Haie-meder, D. Atallah, P. Morice, 2003, Gynecologie, obstetrique & fertilite.

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

Thomas Filleron, Emile Daraï, Denis Querleu, 2016, PloS one.

3 Laparoscopic radical hysterectomy for cervical cancer

M. Canis, G. Mage, C. Pomel, 1995 .

[Laparoscopically extended hysterectomy for cervix cancer: technique, indications and results. Apropos of a series of 41 cases in Clermont].

M. Canis, G. Mage, C. Pomel, 1997, Chirurgie; memoires de l'Academie de chirurgie.

Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.

I. Treilleux, E. Kalbacher, A. Floquet, 2020, Gynecologic oncology.

Survival effect of laparoscopic para‐aortic staging in locally advanced cervical cancer: a retrospective cohort analysis

C. Pomel, G. Ferron, J. Dauplat, 2017, BJOG : an international journal of obstetrics and gynaecology.

[Microinvasive ductal carcinoma of the breast. Role of axillary lymph node dissection].

F. Penault-Llorca, M. D. De Latour, C. Pomel, 1999, Journal de gynecologie, obstetrique et biologie de la reproduction.

Laparoscopic staging of early ovarian cancer.

D. Provencher, C. Pomel, P. Gauthier, 1996, Gynecologic oncology.

Laparoscopic staging of early ovarian cancer.

D. Provencher, C. Pomel, P. Gauthier, 1995, Gynecologic oncology.

[Anatomoclinical study of ovarian cancers in patients with history of hysterectomy for benign pathology].

C. Pomel, M. Dauplat, G. Le Bouedec, 2016, Journal de gynecologie, obstetrique et biologie de la reproduction.

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial.

R. Rouzier, P. Colombo, E. Kalbacher, 2017, European journal of cancer.

Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.

C. Genestie, D. Berton, F. Guyon, 2023, Gynecologic oncology.

Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.

C. Pomel, G. Ferron, L. Gladieff, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Le curage lombo-aortique en question(s)…

M. Canis, C. Pomel, G. Ferron, 2013 .

[Para-aortic lymphadectomy in question…].

M. Canis, C. Pomel, G. Ferron, 2013, Gynecologie, obstetrique & fertilite.

Update on the role of laparoscopy in the treatment of gynaecological malignancy

R. Rouzier, C. Pomel, 2005, Current opinion in obstetrics & gynecology.

[Laparoscopic pelvic exenteration for cervical cancer relapse: preliminary study].

R. Rouzier, C. Uzan, C. Pomel, 2006, Journal de gynecologie, obstetrique et biologie de la reproduction.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer.

S. Msika, F. Guyon, E. Decullier, 2015, Anticancer research.

Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer

C. Pomel, X. Deffieux, D. Castaigne, 2005, International Journal of Gynecologic Cancer.

Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer

C. Pomel, V. Lavoué, J. Bereder, 2023, Annals of Surgical Oncology.

[Morbidity of the trans rectus abdominis musculocutaneous flap in breast reconstruction. Retrospective study about 125 patients].

P. Gimbergues, C. Pomel, G. Le Bouedec, 2003, Annales de chirurgie.

Which Surgical Attitude to Choose in the Context of Non-Resectability of Ovarian Carcinomatosis: Beyond Gross Residual Disease Considerations

P. Morice, A. Rafii, H. Al Thani, 2016, Annals of Surgical Oncology.

Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse

P. Colombo, I. Ray-Coquard, A. Floquet, 2023, International Journal of Gynecological Cancer.

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.

A. Reuss, P. Hillemanns, F. Guyon, 2022, The New England journal of medicine.

EP967 Natural history of patients with BRCA-mutated high grade epithelial ovarian cancer (HGEOC) before the era of PARP inhibitors maintenance in 1st line treatment

R. Rouzier, T. Petit, I. Ray-Coquard, 2019, International Journal of Gynecological Cancer.

Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.

P. Morice, C. Pomel, P. Pautier, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Anatomoclinical study of ovarian cancers in patients with history of hysterectomy for benign pathology].

C. Pomel, G. L. Bouedec, M. Dauplat, 2016, Journal de gynecologie, obstetrique et biologie de la reproduction.

[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].

C. Genestie, F. Guyon, C. Rousset-Jablonski, 2018, Bulletin du cancer.

Results of a prospective phase II national study: Prophylactic radical fimbriectomy (NCT01608074), in women with a documented high risk of breast/ovarian cancer—Final pathological results and outcomes.

F. Guyon, C. Pomel, D. Hudry, 2020 .

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

F. Penault-Llorca, N. Radosevic-Robin, F. Kwiatkowski, 2018, BMC Cancer.

Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer.

F. Mishellany, C. Pomel, G. Chêne, 2009, European journal of cancer.